Drug Shortage Report for TRANDATE
Report ID | 242860 |
Drug Identification Number | 02106272 |
Brand name | TRANDATE |
Common or Proper name | Trandate 100mg |
Company Name | PALADIN PHARMA INC. |
Market Status | MARKETED |
Active Ingredient(s) | LABETALOL HYDROCHLORIDE |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 tabs |
ATC code | C07AG |
ATC description | BETA BLOCKING AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-11-08 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-11-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 MONTREAL, QUEBEC CANADA H4M 2P2 |
Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-11-13 | French | Compare |
v1 | 2024-11-13 | English | Compare |
Showing 1 to 2 of 2